Meeting
2015 ASCO Annual Meeting
Survival following stereotactic body radiation therapy or conventionally fractionated radiation for definitive non-operative treatment of stage I non-small cell lung cancer: A review of the National Cancer Data Base.
Authors
Cliff Grant Robinson
Washington Univ in St Louis, St. Louis, MO
Cliff Grant Robinson , Aalok Patel , Jeffrey D. Bradley , Todd A. DeWees , Sana Rehman , Michael Charles Roach , Daniel Morgensztern , Traves Crabtree , Varun Puri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 7513)
DOI
10.1200/jco.2015.33.15_suppl.7513
Abstract #
7513
Poster Bd #
260
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Long-term outcomes of single and five fraction schedules of stereotactic body radiation therapy for early-stage central or peripheral NSCLC: Neither fractionation nor location matter?
First Author: Karen Huang
Poster
2012 ASCO Annual Meeting
Matched-pair comparison of outcome of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery.
First Author: Julia Shelkey
Poster
2011 ASCO Annual Meeting
Outcomes of stereotactic body radiotherapy in patients with clinical stage I non-small cell lung cancer who are fit to undergo surgery.
First Author: S. Senan
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray